Alteration of expression of several costimulatory signaling molecules required for T-cell activation, including CD28, ICOS, CTLA4, CD40, PD1, CD137, and CD58, have been associated with MS. This evidence concerns the gene TNFRSF9 and myeloid sarcoma.